Table 2.
Univariate cox regression | Multivariate cox regression | ||||||||
---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | |||||||
HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-Value | |
Continuous variable | |||||||||
SUA (per 1.67 mg/dL) |
1.22 | 1.19–1.25 | <0.001 | 1.19 | 1.16–1.23 | <0.001 | 1.06 | 1.03–1.10 | <0.001 |
Categorical variable | |||||||||
Q1 | 1.09 | 0.99–1.21 | 0.093 | 1.11 | 1.01–1.23 | 0.049 | 1.12 | 1.01–1.26 | 0.038 |
Q2 | 0.93 | 0.84–1.03 | 0.172 | 0.93 | 0.84–1.04 | 0.206 | 0.97 | 0.86–1.08 | 0.541 |
Q3 | Reference | Reference | Reference | ||||||
Q4 | 1.10 | 0.99–1.22 | 0.080 | 1.07 | 0.97–1.19 | 0.183 | 1.00 | 0.89–1.12 | 0.996 |
Q5 | 1.67 | 1.52–1.84 | <0.001 | 1.59 | 1.44–1.75 | <0.001 | 1.17 | 1.05–1.30 | 0.005 |
Model 1, Unadjusted model.
Model 2, Adjusted for age and sex.
Model 3, Adjusted for all covariates: age, sex, PCI, comorbidities such as AMI, CHF, hypertension, diabetes mellitus, CKD, anemia, atrial fibrillation, COPD, and stroke, medicine such as drug hyperuricemia hydrochlorothiazide and furosemide, and laboratory examination such as HDL-CAST, CKMB, and LDL-C.